HomeABOS • NASDAQ
Acumen Pharmaceuticals Inc
add
$1.26
3.28%
After Hours:(0.00%)0.00
$1.26
Closed: Mar 14, 4:02:46 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 31.36M | 101.48% |
Net income | -29.77M | -129.72% |
Net profit margin | — | — |
Earnings per share | -0.50 | -108.33% |
EBITDA | -32.25M | -101.23% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 200.34M | -7.00% |
Total assets | 266.98M | -6.77% |
Total liabilities | 49.77M | 716.22% |
Total equity | 217.20M | — |
Shares outstanding | 60.08M | — |
Price to book | 0.34 | — |
Return on assets | -29.02% | — |
Return on capital | -30.97% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -29.77M | -129.72% |
Cash from operations | -24.60M | -90.59% |
Cash from investing | -10.13M | 88.99% |
Cash from financing | -42.00K | -100.03% |
Net change in cash | -34.77M | -294.70% |
Free cash flow | -14.73M | -58.29% |
Previous close
$1.22
Day range
$1.21 - $1.28
Year range
$1.10 - $4.43
Market cap
75.70M USD
Avg Volume
223.29K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
Jan 1, 1996
Headquarters
Website
Employees
51
